Who We Insure

Insurance for Life Sciences by Life Sciences Specialists

Whether in the United States or abroad, Berkley Life Sciences is solely dedicated to providing premiere insurance coverage for today’s top life sciences companies.

Download PDF

Who We Insure

We provide personalized property and casualty insurance products and services to the following life sciences markets:

Digital Health Companies

Companies that focus on the convergence of technology and healthcare, developing digital devices, software applications, and online platforms, improving connectivity and spanning a wide range of uses.

Medical Device Companies

Companies that design, manufacture, and distribute medical instruments, digital health products, and devices for healthcare applications.

Medical Device Software Companies

Organizations that develop software solutions for use in union with medical devices and digital health products to enhance functionality and patient outcomes.

Medical Drug Companies

Pharmaceutical firms involved in the research, development, manufacturing, and marketing of medications for treating various health conditions.

Biologic Companies

Companies that create biologically derived products, including vaccines, blood components, and gene therapies, for medical use.

Dietary Supplement Companies

Firms that produce and distribute vitamins, minerals, and other supplements intended to enhance health and wellness.

Medical Food Companies

Companies that develop and produce foods formulated explicitly for dietary management of diseases or conditions requiring medical supervision.

Cosmetic Drug Companies

Organizations that create products at the intersection of cosmetics and pharmaceuticals, designed to enhance appearance while providing therapeutic benefits.

Product Development Organizations

Companies offering specialized services in developing, testing, and regulatory approval of life sciences products.

Profit & Nonprofit R&D

Entities dedicated to conducting research in life sciences, ranging from private companies to academic and non-profit organizations.

Product Testing Laboratories

Laboratories specializing in the testing and validation of life science products, ensuring compliance with regulatory standards and safety requirements.

Medical Product Distributors

Companies that manage the distribution and supply chain logistics for a wide range of medical products, ensuring their availability to healthcare providers.

Drug Discovery Technology

Firms and organizations that develop technologies and methodologies to accelerate the identification and development of new pharmaceutical compounds.

Bioengineering

Companies and research institutions that apply biology and engineering principles to develop innovative solutions in healthcare, agriculture, and environmental management.

Health Informatics

Non-Medical Biotechnology

Companies focused on biotechnology applications beyond healthcare, including agriculture, environmental management, and industrial processes.

Find a Berkley Life Sciences Agent

Ready for an insurance solution that is tailored to your life sciences business by life sciences specialists?

Find an Agent

The Latest in Life Science

Biomarkers and Parkinson's Disease: Bringing Earlier Diagnosis Within Reach

One of the greatest challenges in Parkinson's disease is that diagnosis often occurs after significant neurological changes have already taken place. Researchers now believe the disease may begin years—or even decades—before the motor symptoms that typically trigger clinical evaluation. By the time symptoms appear, most patients have lost 60% to 80% or more of the dopamine-producing cells in the substantia nigra. This growing understanding has intensified the search for reliable biomarkers that could improve diagnosis, monitor disease progression, guide clinical trial recruitment, and support the development of new therapies.

How the Middle East Conflict Triggered a Helium Shortage—and Threatens Global Life Sciences Supply Chains

Enduring Impact of the Middle East Conflict on the Life Sciences Industry

The element helium is often associated with party balloons and novelty uses. However, the shortage of high-grade helium following the commencement of hostilities in the Middle East on February 28, 2026, presents a significant and underappreciated risk for the life sciences sector. The conflict has created a potentially long-lasting impact on the cost and availability of medicinal products and critical inputs such as helium, which is essential for the operation of certain medical devices.

AI-Enabled Medical Devices: The Broader Compliance Landscape

In a recent post on this blog, we examined the U.S. Food and Drug Administration's (FDA) core regulatory framework for artificial intelligence (AI) and machine learning (ML) enabled medical devices — the Predetermined Change Control Plan (PCCP), the clinical decision support boundary question, cybersecurity mandates, and what the framework means for company legal and regulatory teams. This article examines converging obligations that extend beyond that foundation.